-
An Emerging Treatment for Metastatic Prostate Cancer
A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
August 27: The Week in Cancer News
Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.
by Bradley Jones
-
August 20: The Week in Cancer News
Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.
by Marci A. Landsmann
-
August 13: The Week in Cancer News
Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.
by Kevin McLaughlin
-
Drug Delays Recurrence in People With Early-Stage Breast Cancer
People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
-
July 30: The Week in Cancer News
Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.
by Marci A. Landsmann
-
July 23: The Week in Cancer News
Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.
by Kevin McLaughlin
-
Remote Care
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.
by Jon Kelvey
-
July 16: The Week in Cancer News
A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.
by Bradley Jones
-
Moving Away From the Maximum Tolerated Dose
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Cancer Talk
Study Highlights Challenges in Pancreatic Cancer Staging
Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles
Understanding How High and Low Testosterone Levels Can Treat Prostate CancerUsing high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst